Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

CSL

CSL (CSL)

CSL Limited
일자:
정렬 기준:
 검색 관련기사 보기:ASX:CSL
일자시간출처헤드라인심볼기업
2023/05/0301:44Dow Jones NewsTravere Therapeutics Shares Touch 52-Week Low on FSGS Study DataASX:CSLCSL Limited
2022/11/0300:34Dow Jones NewsArcturus Therapeutics Shares Rise 31% After Vaccine CollaborationASX:CSLCSL Limited
2022/11/0208:27Dow Jones NewsArcturus Up 26% After Hours on CSL Seqirus Vaccine CollaborationASX:CSLCSL Limited
2021/12/1417:54Dow Jones NewsVifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 BillionASX:CSLCSL Limited
2021/12/1416:00Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd UpdateASX:CSLCSL Limited
2021/12/1415:49Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- UpdateASX:CSLCSL Limited
2021/12/1415:24Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaASX:CSLCSL Limited
2021/12/1309:49Dow Jones NewsCSL in Talks With Vifor Pharma Over Potential TransactionASX:CSLCSL Limited
2020/12/1109:57Dow Jones NewsCovid-19 Vaccine Candidate Scrapped After False Positives on HIV TestsASX:CSLCSL Limited
2020/09/0708:06Dow Jones NewsCSL Signs 2 Initial Agreements for Coronavirus Vaccine SupplyASX:CSLCSL Limited
2020/08/1918:46Dow Jones NewsCoronavirus Pandemic Slashes Donations of Lifesaving PlasmaASX:CSLCSL Limited
2019/12/0923:12Dow Jones NewsCSL Bering Gets FDA Orphan Designation for HizentraASX:CSLCSL Limited
2019/05/1422:20Dow Jones NewsHaemonetics Cuts Guidance on CSL Plasma DealASX:CSLCSL Limited
2018/10/2321:58Dow Jones NewsSeqirus Gets FDA Approval for Afluria Quadrivalent in Young ChildrenASX:CSLCSL Limited
2016/12/0120:05NewspaperShould you buy Australian Foundation Investment Co Ltd?ASX:CSLCSL Limited
2016/07/2716:32Dow Jones NewsAustralia Stocks Close Near Flat After Mixed Inflation DataASX:CSLCSL Limited
2016/07/2616:14Dow Jones NewsAustralia Stocks End up Slightly as Key Inflation Data LoomsASX:CSLCSL Limited
2015/10/1608:37Dow Jones NewsCSL Catches Cold from Flu Vaccines Deal with Novartis -- Market TalkASX:CSLCSL Limited
2015/08/1711:19Dow Jones NewsIs A$100 a Share Cursed? -- Market TalkASX:CSLCSL Limited
2015/08/0417:18Dow Jones NewsAustralian Shares End Higher, Helped by Earnings and Sales DataASX:CSLCSL Limited
2015/07/2817:28Dow Jones NewsAustralia Shares End Slightly Down; Energy Stocks RiseASX:CSLCSL Limited
2015/04/2308:20Dow Jones NewsCSL Says CFO Naylor to Lead Influenza-Vaccine BusinessASX:CSLCSL Limited
2015/03/1712:01The Motley FoolWhat do rising U.S. interest rates mean for Australian companies? ASX:CSLCSL Limited
2015/02/1114:54Dow Jones NewsCSL Shaves Guidance as Competition Heats Up-- UpdateASX:CSLCSL Limited
2014/12/0321:18Dow Jones NewsDrooping Commodities Hurt Down Under -- Barron's AsiaASX:CSLCSL Limited
2014/10/2711:31Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine UnitASX:CSLCSL Limited
2014/10/2707:49Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine Unit for $275 MillionASX:CSLCSL Limited
2014/01/2416:22Dow Jones NewsAustralia Shares End Lower on China Growth Concerns, DataASX:CSLCSL Limited
2014/01/1321:20Dow Jones NewsU.S. Stock Futures Are LowerASX:CSLCSL Limited
2014/01/1309:44Dow Jones NewsS&P/ASX 200 Down 0.2% in Quiet TradeASX:CSLCSL Limited
 검색 관련기사 보기:ASX:CSL